MediciNova Free Cash Flow Yield vs Ev To Free Cash Flow Analysis

MNOV Stock

USD 2.07 0.06 2.99%

MediciNova financial indicator trend analysis is infinitely more than just investigating MediciNova recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether MediciNova is a good investment. Please check the relationship between MediciNova Free Cash Flow Yield and its Ev To Free Cash Flow accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MediciNova. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy MediciNova Stock please use our How to Invest in MediciNova guide.

Free Cash Flow Yield vs Ev To Free Cash Flow

Free Cash Flow Yield vs Ev To Free Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of MediciNova Free Cash Flow Yield account and Ev To Free Cash Flow. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between MediciNova's Free Cash Flow Yield and Ev To Free Cash Flow is -0.04. Overlapping area represents the amount of variation of Free Cash Flow Yield that can explain the historical movement of Ev To Free Cash Flow in the same time period over historical financial statements of MediciNova, assuming nothing else is changed. The correlation between historical values of MediciNova's Free Cash Flow Yield and Ev To Free Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow Yield of MediciNova are associated (or correlated) with its Ev To Free Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ev To Free Cash Flow has no effect on the direction of Free Cash Flow Yield i.e., MediciNova's Free Cash Flow Yield and Ev To Free Cash Flow go up and down completely randomly.

Correlation Coefficient

-0.04

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

Ev To Free Cash Flow

A valuation metric comparing the company's enterprise value to its free cash flow, used to evaluate whether a company is undervalued or overvalued.

Most indicators from MediciNova's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MediciNova current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MediciNova. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy MediciNova Stock please use our How to Invest in MediciNova guide.At this time, MediciNova's Tax Provision is fairly stable compared to the past year. Enterprise Value is likely to climb to about 82.8 M in 2024, whereas Selling General Administrative is likely to drop slightly above 4.7 M in 2024.

	2023	2024 (projected)
Extraordinary Items	630K	560K
Reconciled Depreciation	20.3K	18.7K

Extraordinary Items Reconciled Depreciation

MediciNova fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Other Assets	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Other Current Liab	Total Current Liabilities	Property Plant And Equipment Net	Net Debt	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Total Equity	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Other Liab	Non Currrent Assets Other	Property Plant Equipment	Short Long Term Debt Total
Total Assets		1.0	-0.75	0.38	0.9	0.82	0.0	0.76	0.55	0.57	-0.86	0.17	0.89	0.45	0.98	0.9	0.24	-0.49	-0.09	0.56	0.99	0.9	-0.22	-0.51	-0.51	-0.67
Total Stockholder Equity	1.0		-0.71	0.4	0.91	0.8	-0.05	0.74	0.49	0.55	-0.85	0.16	0.9	0.4	0.99	0.9	0.26	-0.51	-0.08	0.54	1.0	0.9	-0.23	-0.53	-0.45	-0.64
Retained Earnings	-0.75	-0.71		-0.12	-0.83	-0.95	-0.49	-0.65	-0.56	-0.48	0.56	-0.27	-0.56	-0.9	-0.64	-0.85	-0.19	0.02	-0.11	-0.48	-0.65	-0.86	-0.07	0.15	0.89	0.82
Other Assets	0.38	0.4	-0.12		0.29	0.2	-0.18	0.31	0.11	0.57	-0.47	-0.13	0.46	0.01	0.41	0.25	-0.08	-0.3	0.02	0.51	0.41	0.25	-0.34	-0.19	0.03	-0.2
Common Stock Shares Outstanding	0.9	0.91	-0.83	0.29		0.93	0.13	0.72	0.41	0.5	-0.71	0.26	0.78	0.58	0.89	0.99	0.31	-0.32	-0.03	0.49	0.89	0.99	-0.05	-0.43	-0.58	-0.71
Other Stockholder Equity	0.82	0.8	-0.95	0.2	0.93		0.44	0.7	0.44	0.42	-0.6	0.23	0.67	0.83	0.75	0.92	0.24	-0.04	0.14	0.41	0.76	0.92	0.09	-0.2	-0.82	-0.77
Total Liab	0.0	-0.05	-0.49	-0.18	0.13	0.44		0.29	0.27	-0.21	0.11	0.16	-0.04	0.77	-0.09	0.13	-0.1	0.7	0.27	-0.22	-0.09	0.13	0.56	0.45	-0.77	-0.32
Other Current Liab	0.76	0.74	-0.65	0.31	0.72	0.7	0.29		0.79	0.62	-0.58	0.29	0.57	0.44	0.76	0.73	0.46	-0.4	-0.25	0.63	0.74	0.73	-0.27	-0.37	-0.56	-0.63
Total Current Liabilities	0.55	0.49	-0.56	0.11	0.41	0.44	0.27	0.79		0.59	-0.52	0.58	0.39	0.38	0.49	0.47	0.21	-0.47	-0.44	0.62	0.48	0.48	-0.39	-0.31	-0.49	-0.48
Property Plant And Equipment Net	0.57	0.55	-0.48	0.57	0.5	0.42	-0.21	0.62	0.59		-0.5	0.1	0.35	0.21	0.53	0.55	0.4	-0.65	-0.23	1.0	0.53	0.56	-0.67	-0.32	-0.21	-0.56
Net Debt	-0.86	-0.85	0.56	-0.47	-0.71	-0.6	0.11	-0.58	-0.52	-0.5		-0.28	-0.92	-0.26	-0.85	-0.73	0.12	0.54	0.18	-0.49	-0.86	-0.73	0.26	0.42	0.3	0.61
Accounts Payable	0.17	0.16	-0.27	-0.13	0.26	0.23	0.16	0.29	0.58	0.1	-0.28		0.22	0.17	0.18	0.29	-0.11	-0.31	-0.52	0.12	0.15	0.29	-0.18	-0.27	-0.2	0.04
Cash	0.89	0.9	-0.56	0.46	0.78	0.67	-0.04	0.57	0.39	0.35	-0.92	0.22		0.3	0.91	0.77	-0.16	-0.41	-0.15	0.33	0.91	0.77	-0.1	-0.51	-0.36	-0.49
Non Current Assets Total	0.45	0.4	-0.9	0.01	0.58	0.83	0.77	0.44	0.38	0.21	-0.26	0.17	0.3		0.31	0.59	0.05	0.38	0.32	0.2	0.33	0.59	0.33	0.17	-0.96	-0.68
Cash And Short Term Investments	0.98	0.99	-0.64	0.41	0.89	0.75	-0.09	0.76	0.49	0.53	-0.85	0.18	0.91	0.31		0.87	0.26	-0.55	-0.17	0.52	1.0	0.87	-0.24	-0.57	-0.38	-0.59
Common Stock Total Equity	0.9	0.9	-0.85	0.25	0.99	0.92	0.13	0.73	0.47	0.55	-0.73	0.29	0.77	0.59	0.87		0.27	-0.36	-0.06	0.55	0.87	1.0	-0.08	-0.44	-0.61	-0.74
Short Term Investments	0.24	0.26	-0.19	-0.08	0.31	0.24	-0.1	0.46	0.21	0.4	0.12	-0.11	-0.16	0.05	0.26	0.27		-0.31	-0.03	0.41	0.26	0.27	-0.32	-0.17	-0.07	-0.23
Non Current Liabilities Total	-0.49	-0.51	0.02	-0.3	-0.32	-0.04	0.7	-0.4	-0.47	-0.65	0.54	-0.31	-0.41	0.38	-0.55	-0.36	-0.31		0.54	-0.67	-0.54	-0.36	0.8	0.67	-0.3	0.09
Other Current Assets	-0.09	-0.08	-0.11	0.02	-0.03	0.14	0.27	-0.25	-0.44	-0.23	0.18	-0.52	-0.15	0.32	-0.17	-0.06	-0.03	0.54		-0.26	-0.11	-0.07	0.34	0.51	-0.2	-0.08
Property Plant And Equipment Gross	0.56	0.54	-0.48	0.51	0.49	0.41	-0.22	0.63	0.62	1.0	-0.49	0.12	0.33	0.2	0.52	0.55	0.41	-0.67	-0.26		0.52	0.55	-0.68	-0.34	-0.22	-0.56
Total Current Assets	0.99	1.0	-0.65	0.41	0.89	0.76	-0.09	0.74	0.48	0.53	-0.86	0.15	0.91	0.33	1.0	0.87	0.26	-0.54	-0.11	0.52		0.87	-0.25	-0.55	-0.39	-0.6
Common Stock	0.9	0.9	-0.86	0.25	0.99	0.92	0.13	0.73	0.48	0.56	-0.73	0.29	0.77	0.59	0.87	1.0	0.27	-0.36	-0.07	0.55	0.87		-0.09	-0.44	-0.61	-0.74
Other Liab	-0.22	-0.23	-0.07	-0.34	-0.05	0.09	0.56	-0.27	-0.39	-0.67	0.26	-0.18	-0.1	0.33	-0.24	-0.08	-0.32	0.8	0.34	-0.68	-0.25	-0.09		0.36	-0.29	-0.02
Non Currrent Assets Other	-0.51	-0.53	0.15	-0.19	-0.43	-0.2	0.45	-0.37	-0.31	-0.32	0.42	-0.27	-0.51	0.17	-0.57	-0.44	-0.17	0.67	0.51	-0.34	-0.55	-0.44	0.36		0.0	0.07
Property Plant Equipment	-0.51	-0.45	0.89	0.03	-0.58	-0.82	-0.77	-0.56	-0.49	-0.21	0.3	-0.2	-0.36	-0.96	-0.38	-0.61	-0.07	-0.3	-0.2	-0.22	-0.39	-0.61	-0.29	0.0		0.66
Short Long Term Debt Total	-0.67	-0.64	0.82	-0.2	-0.71	-0.77	-0.32	-0.63	-0.48	-0.56	0.61	0.04	-0.49	-0.68	-0.59	-0.74	-0.23	0.09	-0.08	-0.56	-0.6	-0.74	-0.02	0.07	0.66

Click cells to compare fundamentals

MediciNova Account Relationship Matchups

MediciNova fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	79.2M	75.4M	87.4M	74.2M	66.3M	62.3M
Total Stockholder Equity	74.9M	71.3M	83.7M	70.2M	62.4M	50.9M
Retained Earnings	(369.1M)	(382.9M)	(393.1M)	(407.1M)	(415.7M)	(394.9M)
Other Assets	59.8K	5.0M	97.9M	92.8K	106.7K	101.4K
Common Stock Shares Outstanding	43.2M	44.4M	48.6M	49.0M	49.0M	24.6M
Liabilities And Stockholders Equity	79.2M	75.4M	87.4M	74.2M	66.3M	62.3M
Other Stockholder Equity	444.0M	454.3M	476.8M	477.4M	478.1M	331.0M
Total Liab	4.3M	4.1M	3.7M	3.9M	3.9M	3.7M
Other Current Liab	1.8M	1.6M	2.3M	2.6M	2.1M	1.6M
Total Current Liabilities	2.2M	2.2M	2.8M	3.2M	3.3M	4.5M
Property Plant And Equipment Net	40.6K	55.7K	881.8K	674.8K	621.2K	652.3K
Net Debt	(63.4M)	(59.9M)	(71.3M)	(18.3M)	(50.8M)	(48.2M)
Accounts Payable	451.3K	616.6K	402.7K	424.6K	1.0M	722.3K
Cash	63.8M	60.0M	71.4M	18.5M	51.0M	32.1M
Non Current Assets Total	14.9M	14.7M	15.4M	15.2M	15.1M	15.4M
Cash And Short Term Investments	63.8M	60.0M	71.4M	58.5M	51.0M	35.9M
Common Stock Total Equity	43.9K	45.0K	49.0K	49.0K	56.4K	31.3K
Non Current Liabilities Total	2.1M	1.9M	896.5K	725.4K	612.5K	581.8K
Other Current Assets	511.9K	680.2K	578.0K	499.4K	174.9K	166.2K
Property Plant And Equipment Gross	40.6K	55.7K	1.3M	1.1M	1.1M	1.1M
Total Current Assets	64.3M	60.7M	72.0M	59.0M	51.2M	38.1M
Common Stock	43.9K	45.0K	49.0K	49.0K	56.4K	32.4K
Other Liab	1.9M	1.9M	1.9M	201.8K	232.1K	220.5K
Non Currrent Assets Other	459.8K	246.2K	115.5K	92.8K	74.2K	70.4K
Accumulated Other Comprehensive Income	(92.7K)	(88.2K)	(98.9K)	(115.3K)	(118.1K)	(124.0K)
Property Plant Equipment	40.6K	55.7K	57.6K	45.3K	40.7K	38.7K
Short Long Term Debt Total	399.3K	184.8K	132.0K	157.5K	215.9K	205.1K
Net Tangible Assets	65.3M	61.7M	74.1M	60.6M	69.7M	41.2M
Retained Earnings Total Equity	(369.1M)	(382.9M)	(393.1M)	(407.1M)	(366.4M)	(384.7M)
Capital Surpluse	444.0M	454.3M	476.8M	477.4M	549.1M	427.3M
Net Invested Capital	74.9M	71.3M	83.7M	70.2M	62.4M	74.5M
Net Working Capital	62.1M	58.5M	69.2M	55.8M	47.9M	59.6M
Capital Stock	43.9K	45.0K	49.0K	49.0K	56.4K	51.0K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for MediciNova Stock Analysis

When running MediciNova's price analysis, check to measure MediciNova's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MediciNova is operating at the current time. Most of MediciNova's value examination focuses on studying past and present price action to predict the probability of MediciNova's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MediciNova's price. Additionally, you may evaluate how the addition of MediciNova to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC